124
A. El-Faham et al. / Journal of Molecular Structure 1125 (2016) 121e135
(KBr): 3426 (NH), 3293 (NH), 1589 (C]N), 1514 (C]N), 1438 (C]C)
cmꢀ1; 1H NMR (CDCl3)
: 1.53e1.60 (6H, m, 3CH2, piperidine), 2.25
3. Crystal structures determination and refinement
d
(3H, s, CH3), 3.65e3.75 (12H, m, 2 CH2N, piperidine, 2 CH2O and 2
CH2N, morpholine), 6.82e6.87(2H, m, AreH), 7.22 (1H,t, J ¼ 7.2 Hz,
AreH), 7.32 (1H, d, J ¼ 8.0 Hz, AreH), 8.30 (1H, brs, NH);13C NMR
The compounds 10c, 10d, 10e and 10f were obtained as single
crystals by slow evaporation from their solutions at room temper-
ature. Data were collected on a Bruker APEX-II D8 Venture area
(CDCl3)
d
: 11.9 (CH3), 24.7, 25.7 (CH2, piperidine), 43.8 (CH2O,
diffractometer, equipped with graphite monochromatic Cu Ka ra-
morpholine), 44.6 (CH2, piperidine), 66.7 (CH2N, morpholine),116.1,
116.8, 119.2, 128.3, 129.3, 146.9 (5 phenyl carbons and CeNH2),
159.1, 163.4, 164.4 (C]N). Elemental Anal. Calc. for C20H28N8O
(396.50): C, 60.59; H, 7.12; N, 28.26. Found C, 60.87; H, 7.32; N,
28.51.
diation at 100 (2) K. Cell refinement and data reduction were car-
ried out by Bruker SAINT, SHELXS-97 [52,53] was used to solve
structure. The final refinement was carried out by full-matrix least-
squares techniques with anisotropic thermal data for non-
hydrogen atoms on f. CCDC numbers 1431262, 1431201, 1430929
and 1431178 contain the supplementary crystallographic data for
these compounds can be obtained free of charge from the Cam-
2.2.12. (E)-2-[1-(2-(4-morpholino-6-(piperidin-1-yl)-1,3,5-triazin-
2-yl)hydrazono] ethyl)phenol (10h)
White solid in yield 72% (A), 94% (B); mp164e165 ꢁC; IR (KBr):
3432 (NH), 3298 (OH), 1591 (C]N), 1534(C]N), 1438 (C]C)cmꢀ1
;
1H NMR (CDCl3)
d: 1.53e1.60 (6H, m, 3CH2, piperidine), 2.27 (3H, s,
4. Computational details
CH3), 3.62e3.79 (12H, m, 2CH2N, piperidine, 2 CH2O and 2CH2N,
morpholine), 6.79(1H, t, J ¼ 6.4 Hz, AreH), 6.91 (1H, d, J ¼ 8.0 Hz,
AreH), 7.17(1H, m, AreH), 7.36 (1H, d, J ¼ 6.8 Hz, AreH), 10.20 (1H,
All calculations for the studied compounds were carried out
using Gaussian 03 software [54]. Without any symmetry re-
strictions and starting with the X-ray structures as input files, ge-
ometry optimization followed by frequency calculations were
performed by DFT/B3LYP method using 6e311G(d,p) basis set. No
negative vibrational modes were obtained. The optimized geome-
tries, frontier molecular orbitals (FMOs) and molecular electrostatic
potential (MEP) maps were drawn using GaussView4.1 [55]. The
charge distribution on the atomic sites was deduced using natural
bond orbital (NBO) method [56] at the DFT/B3LYP level. The nuclear
magnetic resonance (NMR) chemical shifts calculations were per-
formed using GIAO method [57,58] while the origin of the elec-
tronic spectra was deduced using time dependent density TD-DFT
method.
brs, NH), 12.89 (1H, s, OH); 13C NMR (CDCl3)
d: 12.9 (CH3), 24.5, 25.7
(CH2, piperidine), 44.3(CH2O, morpholine), 66.6 (CH2N, piperidine),
66.9 (CH2N, morpholine),117.9, 118.5,119.6,127.4,128.9,130.9,159.1
(5 phenyl carbons and CeOH), 163.4, 164.4 (C]N). Elemental Anal.
Calc. for C20H27N7O2 (397.22): C, 60.44; H, 6.85; N, 24.67. Found C,
60.71; H, 7.01; N, 24.89.
2.2.13. (E)-2-[1-(2-(4-methoxy-6-morpholino-1,3,5-triazin-2-yl)
hydrazono)ethyl] aniline (10i)
Yellow solid in yield 72% (A), 94% (B); mp168e171 ꢁC; IR (KBr):
3427 (NH), 3268 (NH), 1650 (C]N), 1519 (C]N), 1438 (C]C)cmꢀ1
;
1H NMR (CDCl3)
d: 2.29 (3H, s, CH3), 3.68 (4H, brs, 2 CH2O, mor-
pholine), 3.83 (4H, brs, 2 CH2N, morpholine), 3.92 (3H, s, OCH3),
6.41(2H, brs, 2NH), 6.65e6.71 (2H, m, AreH), 7.09(1H, t, J ¼ 7.6 Hz,
AreH), 7.36 (1H, d, J ¼ 8.4 Hz, AreH), 8.11 (1H, brs, NH); 13C NMR
5. Biological screening (MTT-ASSAY)
(CDCl3)
d
: 12.8 (CH3), 43.9 (CH2, morpholine), 54.3 (OCH3), 66.7
The anti-proliferative activities of the compounds against cancer
cell lines had been demonstrated using MTT-Assay [59] (supporting
information). The metabolic activities of three cancer cell lines,
including the lung carcinoma cell line A549, the hepatocellular
carcinoma HepG2 cell line, and the breast carcinoma cell line MCF-
7 (Table S2, supporting information), were measured in absence
and presence of the compounds. Growth inhibitions were
(CH2N, morpholine), 116.25, 116.9, 118.9, 128.4, 129.6, 130.4, 146.9,
147.7 (5 phenyl carbons and CeNH2), 159.1, 161.9, 165.8 (C]N).
Elemental Anal. Calc. for C16H21N7O2 (343.39): C, 55.96; H, 6.16; N,
28.55. Found C, 56.16; H, 6.09; N, 28.79.
2.2.14. (E)-2-[1-(2-(4-methoxy-6-(piperidin-1-yl)-1,3,5-triazin-2-
yl)hydrazono)ethyl] phenol (10j)
measured in 96-well plates. Aliquots of 120 mL of the suspended
Pale solid in yield 70% (A), 95% (B); mp 150e152 ꢁC; IR (KBr,):
cells (50,000 mLꢀ1) were seeded into wells of 96-well plate und
cultivated at 37 ꢁC, 5% CO2, and high humidity atmosphere. After
3430 (NH), 3284 (OH), 1650 (C]N), 1597 (C]N), 1498 (C]C) cmꢀ1
;
1H NMR (DMSO-d6)
d: 1.54e1.68 (6H, m, 3CH2, piperidine), 2.31
24 h 60
mL of a serial dilution of the inhibitor(S) had been given to
(3H, s, CH3), 3.82e3.95 (4H, m, 2 CH2N, piperidine), 3.91(3H, s,
OCH3), 6.90 (1H, t, J ¼ 7.5 Hz, AreH), 7.24 (1H,t, J ¼ 8.0 Hz, AreH),
7.63 (1H, d, J ¼ 6.4 Hz, AreH), 10.38 (1H, s, NH), 13.40 (1H, brs,OH).
Elemental Anal. Calc. for C17H22N6O2 (342.40): C, 59.63; H, 6.48; N,
24.54. Found C, 59.85; H, 6.27; N, 24.81.
each well. After 3 days of incubations, growth were determined the
MTT assay. Briefly, 20 ml MTT (5 mg/mL in PBS) were added to each
well, and the plates were incubated for 2 h at 37 ꢁC, and 5% CO2-
atmosphere in the cell incubator. The supernatants were then
discarded and 200 ml of isopropanol/HCl were added to each well
and mixed to dissolve the formazan crystals. The absorbance was
then read at 560 nm using a plate reader (Thermo Scientific, USA).
The viability of the cells was calculated by dividing the absorbance
average of the treated cells by the absorbance average of the control
cells multiply 100%. The IC50 values were defined as sample con-
centration inhibiting 50% of cell growth. The activities of the cells
were plotted against the concentration of the drugs, and the IC50
values were calculated from the regression curve.
2.2.15. (E)-2-[1-(2-(4-methoxy-6-(piperidin-1-yl)-1,3,5-triazin-2-
yl)hydrazono)ethyl]aniline (10k)
Pale yellow solid in yield71% (A), 93% (B); mp140e141 ꢁC; IR
(KBr): 3428 (NH), 3292 (NH), 1646 (C]N), 1617 (C]N), 1554 (C]
N), 1482 (C]C) cmꢀ1 1H NMR (CDCl3)
; d: 1.54e1.66 (6H, m, 3CH2,
piperidine), 2.27 (3H, s, CH3), 3.78 (4H, brs, 2 CH2N, piperidine),
3.91 (3H, s, OCH3), 6.64e6.70 (2H, m, AreH), 7.10 (1H, t, J ¼ 6.8 Hz,
AreH), 7.36 (1H, d, J ¼ 9.6 Hz, AreH), 8.19 (1H, s, NH); 13C NMR
(CDCl3)
d: 12.4 (CH3), 24.5, 25.7 (CH2, piperidine), 44.4 (CH2N,
6. Results and discussion
piperidine), 53.9 (OCH3), 115.9, 116.7, 118.9, 128.1, 129.4146.9 (5
phenyl carbons and CeNH2), 159.1, 163.4, 164.4 (C]N). Elemental
Anal. Calc. for C17H23N7O (341.42): C, 59.81; H, 6.79; N, 28.72. Found
C, 60.01; H, 6.93; N, 28.58.
6.1. Synthesis
The first and second chlorine atoms of 2,4,6-trichloro-1,3,5-